Unknown

Dataset Information

0

Discovery of 5-Hydroxy-1,4-naphthoquinone (Juglone) Derivatives as Dual Effective Agents Targeting Platelet-Cancer Interplay through Protein Disulfide Isomerase Inhibition.


ABSTRACT: In this study, a series of 2- and/or 3-substituted juglone derivatives were designed and synthesized. Among them, 9, 18, 22, 30, and 31 showed stronger inhibition activity against cell surface PDI or recombinant PDI and higher inhibitory effects on U46619- and/or collagen-induced platelet aggregation than juglone. The glycosylated derivatives 18 and 22 showed improved selectivity for inhibiting the proliferation of multiple myeloma RPMI 8226 cells, and the IC50 values reached 61 and 48 nM, respectively, in a 72 h cell viability test. In addition, 18 and 22 were able to prevent tumor cell-induced platelet aggregation and platelet-enhanced tumor cell proliferation. The molecular docking showed the amino acid residues Gln243, Phe440, and Leu443 are important for the compound-protein interaction. Our results reveal the potential of juglone derivatives to serve as novel antiplatelet and anticancer dual agents, which are available to interrupt platelet-cancer interplay through covalent binding to PDI catalytic active site.

SUBMITTER: Juang YP 

PROVIDER: S-EPMC10945480 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Discovery of 5-Hydroxy-1,4-naphthoquinone (Juglone) Derivatives as Dual Effective Agents Targeting Platelet-Cancer Interplay through Protein Disulfide Isomerase Inhibition.

Juang Yu-Pu YP   Tsai Ju-Ying JY   Gu Wan-Lan WL   Hsu Hui-Ching HC   Lin Chao-Lung CL   Wu Chin-Chung CC   Liang Pi-Hui PH  

Journal of medicinal chemistry 20240221 5


In this study, a series of 2- and/or 3-substituted juglone derivatives were designed and synthesized. Among them, <b>9</b>, <b>18</b>, <b>22</b>, <b>30</b>, and <b>31</b> showed stronger inhibition activity against cell surface PDI or recombinant PDI and higher inhibitory effects on U46619- and/or collagen-induced platelet aggregation than juglone. The glycosylated derivatives <b>18</b> and <b>22</b> showed improved selectivity for inhibiting the proliferation of multiple myeloma RPMI 8226 cells  ...[more]

Similar Datasets

| S-EPMC4056940 | biostudies-literature
| S-EPMC7417813 | biostudies-literature
| S-EPMC9152545 | biostudies-literature
| S-EPMC6480589 | biostudies-literature
| S-EPMC6337875 | biostudies-literature
| S-EPMC6507621 | biostudies-literature
| S-EPMC6464389 | biostudies-literature
| S-EPMC3366406 | biostudies-literature
| S-EPMC10734522 | biostudies-literature
| S-EPMC8509387 | biostudies-literature